vs
Side-by-side financial comparison of MONRO, INC. (MNRO) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
MONRO, INC. is the larger business by last-quarter revenue ($293.4M vs $164.7M, roughly 1.8× PTC THERAPEUTICS, INC.). MONRO, INC. runs the higher net margin — 3.8% vs -82.0%, a 85.8% gap on every dollar of revenue. On growth, MONRO, INC. posted the faster year-over-year revenue change (-4.0% vs -22.7%). MONRO, INC. produced more free cash flow last quarter ($9.1M vs $-36.6M). Over the past eight quarters, MONRO, INC.'s revenue compounded faster (-2.7% CAGR vs -11.5%).
Monro, Inc. is an automotive services company founded and headquartered in Rochester, New York, U.S. As of 2025, Monro has 1,260 locations making them the second-largest automotive services company in North America after Driven Brands by number of locations and by revenue.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
MNRO vs PTCT — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $293.4M | $164.7M |
| Net Profit | $11.1M | $-135.0M |
| Gross Margin | 34.9% | — |
| Operating Margin | 6.3% | -43.3% |
| Net Margin | 3.8% | -82.0% |
| Revenue YoY | -4.0% | -22.7% |
| Net Profit YoY | 143.1% | -104.8% |
| EPS (diluted) | $0.35 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $293.4M | $164.7M | ||
| Q3 25 | $288.9M | $211.0M | ||
| Q2 25 | $301.0M | $178.9M | ||
| Q1 25 | $295.0M | $1.2B | ||
| Q4 24 | $305.8M | $213.2M | ||
| Q3 24 | $301.4M | $196.8M | ||
| Q2 24 | $293.2M | $186.7M | ||
| Q1 24 | $310.1M | $210.1M |
| Q4 25 | $11.1M | $-135.0M | ||
| Q3 25 | $5.7M | $15.9M | ||
| Q2 25 | $-8.1M | $-64.8M | ||
| Q1 25 | $-21.3M | $866.6M | ||
| Q4 24 | $4.6M | $-65.9M | ||
| Q3 24 | $5.6M | $-106.7M | ||
| Q2 24 | $5.9M | $-99.2M | ||
| Q1 24 | $3.7M | $-91.6M |
| Q4 25 | 34.9% | — | ||
| Q3 25 | 35.7% | — | ||
| Q2 25 | 35.5% | — | ||
| Q1 25 | 33.0% | — | ||
| Q4 24 | 34.3% | — | ||
| Q3 24 | 35.3% | — | ||
| Q2 24 | 37.2% | — | ||
| Q1 24 | 35.5% | — |
| Q4 25 | 6.3% | -43.3% | ||
| Q3 25 | 4.4% | 1.4% | ||
| Q2 25 | -2.0% | -19.5% | ||
| Q1 25 | -8.1% | 82.5% | ||
| Q4 24 | 3.3% | -76.2% | ||
| Q3 24 | 4.4% | -27.7% | ||
| Q2 24 | 4.5% | -21.5% | ||
| Q1 24 | 3.3% | -21.6% |
| Q4 25 | 3.8% | -82.0% | ||
| Q3 25 | 2.0% | 7.5% | ||
| Q2 25 | -2.7% | -36.3% | ||
| Q1 25 | -7.2% | 73.7% | ||
| Q4 24 | 1.5% | -30.9% | ||
| Q3 24 | 1.9% | -54.2% | ||
| Q2 24 | 2.0% | -53.1% | ||
| Q1 24 | 1.2% | -43.6% |
| Q4 25 | $0.35 | $-1.63 | ||
| Q3 25 | $0.18 | $0.20 | ||
| Q2 25 | $-0.28 | $-0.83 | ||
| Q1 25 | $-0.74 | $10.04 | ||
| Q4 24 | $0.15 | $-0.85 | ||
| Q3 24 | $0.18 | $-1.39 | ||
| Q2 24 | $0.19 | $-1.29 | ||
| Q1 24 | $0.12 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.9M | $1.9B |
| Total DebtLower is stronger | $45.0M | — |
| Stockholders' EquityBook value | $604.9M | $-205.3M |
| Total Assets | $1.6B | $2.9B |
| Debt / EquityLower = less leverage | 0.07× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.9M | $1.9B | ||
| Q3 25 | $10.5M | $1.7B | ||
| Q2 25 | $7.8M | $2.0B | ||
| Q1 25 | $20.8M | $2.0B | ||
| Q4 24 | $10.2M | $1.1B | ||
| Q3 24 | $20.9M | $1.0B | ||
| Q2 24 | $18.7M | $1.1B | ||
| Q1 24 | $6.6M | $884.8M |
| Q4 25 | $45.0M | — | ||
| Q3 25 | $60.0M | — | ||
| Q2 25 | $71.5M | — | ||
| Q1 25 | $61.3M | — | ||
| Q4 24 | $59.3M | — | ||
| Q3 24 | $62.0M | — | ||
| Q2 24 | $112.0M | — | ||
| Q1 24 | $102.0M | — |
| Q4 25 | $604.9M | $-205.3M | ||
| Q3 25 | $601.7M | $-155.8M | ||
| Q2 25 | $604.9M | $-206.5M | ||
| Q1 25 | $620.8M | $-185.8M | ||
| Q4 24 | $648.9M | $-1.1B | ||
| Q3 24 | $651.9M | $-1.1B | ||
| Q2 24 | $654.4M | $-980.2M | ||
| Q1 24 | $656.8M | $-893.9M |
| Q4 25 | $1.6B | $2.9B | ||
| Q3 25 | $1.6B | $2.6B | ||
| Q2 25 | $1.6B | $2.6B | ||
| Q1 25 | $1.6B | $2.7B | ||
| Q4 24 | $1.7B | $1.7B | ||
| Q3 24 | $1.7B | $1.8B | ||
| Q2 24 | $1.7B | $1.9B | ||
| Q1 24 | $1.7B | $1.8B |
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.10× | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.10× | — | ||
| Q4 24 | 0.09× | — | ||
| Q3 24 | 0.10× | — | ||
| Q2 24 | 0.17× | — | ||
| Q1 24 | 0.16× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $17.8M | $-34.3M |
| Free Cash FlowOCF − Capex | $9.1M | $-36.6M |
| FCF MarginFCF / Revenue | 3.1% | -22.3% |
| Capex IntensityCapex / Revenue | 3.0% | 1.4% |
| Cash ConversionOCF / Net Profit | 1.60× | — |
| TTM Free Cash FlowTrailing 4 quarters | $49.6M | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $17.8M | $-34.3M | ||
| Q3 25 | $32.3M | $-66.3M | ||
| Q2 25 | $-1.9M | $-58.3M | ||
| Q1 25 | $28.9M | $870.1M | ||
| Q4 24 | $14.8M | $-30.0M | ||
| Q3 24 | $62.6M | $-77.0M | ||
| Q2 24 | $25.6M | $-71.5M | ||
| Q1 24 | $-5.3M | $70.8M |
| Q4 25 | $9.1M | $-36.6M | ||
| Q3 25 | $26.6M | $-69.7M | ||
| Q2 25 | $-9.3M | $-59.6M | ||
| Q1 25 | $23.2M | $868.4M | ||
| Q4 24 | $7.9M | $-33.8M | ||
| Q3 24 | $57.6M | $-77.5M | ||
| Q2 24 | $16.8M | $-78.8M | ||
| Q1 24 | $-11.9M | $61.2M |
| Q4 25 | 3.1% | -22.3% | ||
| Q3 25 | 9.2% | -33.1% | ||
| Q2 25 | -3.1% | -33.3% | ||
| Q1 25 | 7.9% | 73.8% | ||
| Q4 24 | 2.6% | -15.8% | ||
| Q3 24 | 19.1% | -39.4% | ||
| Q2 24 | 5.7% | -42.2% | ||
| Q1 24 | -3.8% | 29.1% |
| Q4 25 | 3.0% | 1.4% | ||
| Q3 25 | 2.0% | 1.6% | ||
| Q2 25 | 2.5% | 0.7% | ||
| Q1 25 | 1.9% | 0.1% | ||
| Q4 24 | 2.2% | 1.8% | ||
| Q3 24 | 1.6% | 0.3% | ||
| Q2 24 | 3.0% | 4.0% | ||
| Q1 24 | 2.1% | 4.6% |
| Q4 25 | 1.60× | — | ||
| Q3 25 | 5.71× | -4.17× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | 3.23× | — | ||
| Q3 24 | 11.08× | — | ||
| Q2 24 | 4.37× | — | ||
| Q1 24 | -1.42× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MNRO
| Tires | $150.2M | 51% |
| Maintenance | $73.5M | 25% |
| Brakes | $35.1M | 12% |
| Steering | $24.9M | 8% |
| Batteries | $6.2M | 2% |
| Exhaust | $3.2M | 1% |
PTCT
Segment breakdown not available.
